Compounds > vancomycin
Page last updated: 2024-08-21

vancomycin and Bowel Diseases, Inflammatory

vancomycin has been researched along with Bowel Diseases, Inflammatory in 30 studies

Research

Studies (30)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (6.67)29.6817
2010's21 (70.00)24.3611
2020's7 (23.33)2.80

Authors

AuthorsStudies
Bergeron, MG; Domingo, MC; Giroux, R; Huletsky, A; Picard, FJ1
Bozward, AG; Oo, YH; Osei-Bordom, D; Ronca, V1
Hetjens, L; Li, H; Li, X; Pich, A; Shi, X; Wolter, N1
Farraye, FA; Hashash, JG; Khanna, S; Koop, AH; Pardi, DS; Travers, PM1
Abdelbary, MMH; Conrads, G; Hammad, MI1
Andersen, M; Lei, DK; Ollech, JE; Rubin, DT; Sossenheimer, P; Weisshof, R; Zmeter, N1
Chan, PKS; Jiang, X; Lee, WH; Ng, SC; You, JHS1
Dong, J; Du, W; Han, W1
Agus, A; Da Costa, G; Danne, C; Dupraz, L; Langella, P; Magniez, A; Mayeur, C; Michaudel, C; Michel, ML; Planchais, J; Richard, ML; Rolhion, N; Sokol, H; Spatz, M; Touch, S; Trottein, F1
Axelrad, JE; Green, PHR; Joelson, A; Lawlor, G; Lebwohl, B; Lichtiger, S; Nobel, YR1
Elson, CO; Harbour, SN; Khafipour, E; Kolde, R; Latorre, IJ; Moon, JJ; Schoeb, TR; Tun, HM; Turner, H; Weaver, CT; Xavier, RJ; Zhao, Q1
Ledder, O; Lev-Tzion, R; Shteyer, E; Tan, MLN; Turner, D; Uhlig, HH1
Biedermann, L1
Battat, R; Bessissow, T; D'Aoust, J1
Ali, AH; Buness, CW; Carey, EJ; Cox, KL; Damman, JL; Lindor, KD; Rodriguez, EA1
Corr, SC; De Souza, DP; de Zoete, MR; Flavell, RA; Gerlic, M; Harapas, CR; Kanojia, K; Kile, BT; Kim, ML; Kouremenos, KA; Masters, SL; McConville, MJ; Mielke, LA; Ogura, Y; Papenfuss, AT; Penington, JS; Preaudet, A; Putoczki, TL; Radford-Smith, GL; Simms, LA; Souza-Fonseca-Guimaraes, F; Tye, H; Wilcox, SA; Wockner, LF; Yu, CH; Zakrzewski, M1
Cho, S; Dubinsky, MC; Grinspan, A; Hirten, R; Spencer, E1
Binion, DG; Hashash, JG1
Berel, D; Dezfoli, S; Dubinsky, M; Fleshner, P; Grein, J; Hirsch, J; Horton, HA; Ippoliti, A; Kaur, M; McGovern, D; Melmed, GY; Murthy, R; Shih, D; Targan, SR; Vasiliauskas, EA1
Nakanishi, Y; Ohteki, T; Sato, T1
Bass, JA; Butler, D; McCulloh, R; Myers, A; Pahud, B; St Peter, SD; Torres-Torres, S1
Cohen, MB1
Banaszkiewicz, A; Brazier, JS; Młynarczyk, G; Obuch-Woszczatyński, P; Pituch, H; Radzikowski, A; van Belkum, A; Wultańska, D1
Cohen, MB; Hart, KW; Lindsell, CJ; Mann, EA; Mezoff, E1
Leung, W; Nguyen, GC; Weizman, AV1
Vaishnavi, C1
Borgundvaag, B; Croitoru, K; Gnanasuntharam, P; Le, B; Leung, W; Malhi, G; McGeer, AJ; Nguyen, GC; Silverberg, MS; Steinhart, AH; Thanabalan, R; Weizman, AV; Willey, BM1
Coffin, SE; Feng, R; Haynes, K; Kronman, MP; Zaoutis, TE1
Abarbanel, DN; Benavides, JA; Cox, K; Cox, KL; Davies, Y; Marlen, N; Nadeau, KC; Seki, SM1
Li, Y; Qian, J; Queener, E; Shen, B1

Reviews

5 review(s) available for vancomycin and Bowel Diseases, Inflammatory

ArticleYear
Gut-Liver Immune Traffic: Deciphering Immune-Pathogenesis to Underpin Translational Therapy.
    Frontiers in immunology, 2021, Volume: 12

    Topics: Antibodies, Monoclonal, Humanized; Bile Acids and Salts; Cholangitis, Sclerosing; Fecal Microbiota Transplantation; Gastrointestinal Microbiome; Humans; Immune Checkpoint Inhibitors; Inflammatory Bowel Diseases; Intestinal Mucosa; Liver; Liver Cirrhosis, Biliary; Receptors, Cytoplasmic and Nuclear; T-Lymphocytes, Regulatory; Vancomycin

2021
Management of inflammatory bowel disease with
    World journal of gastroenterology, 2017, Jul-21, Volume: 23, Issue:27

    Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Colectomy; Glucocorticoids; Hospitalization; Humans; Immunologic Factors; Immunosuppression Therapy; Incidence; Inflammatory Bowel Diseases; Risk Factors; Symptom Flare Up; Vancomycin

2017
Review article: the evidence that vancomycin is a therapeutic option for primary sclerosing cholangitis.
    Alimentary pharmacology & therapeutics, 2018, Volume: 47, Issue:7

    Topics: Cholangitis, Sclerosing; Colitis, Ulcerative; Disease Progression; Humans; Inflammatory Bowel Diseases; Treatment Outcome; Vancomycin

2018
Managing Clostridium difficile in inflammatory bowel disease (IBD).
    Current gastroenterology reports, 2014, Volume: 16, Issue:7

    Topics: Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Feces; Humans; Inflammatory Bowel Diseases; Opportunistic Infections; Tissue Transplantation; Vancomycin

2014
Clostridium difficile infection: clinical spectrum and approach to management.
    Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology, 2011, Volume: 30, Issue:6

    Topics: Aminoglycosides; Anti-Infective Agents; Clostridioides difficile; Clostridium Infections; Dietary Supplements; Digestive System Surgical Procedures; Disease Management; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Routes; Fidaxomicin; Humans; Ileus; Immunoglobulins, Intravenous; Inflammatory Bowel Diseases; Metronidazole; Severity of Illness Index; Vancomycin; Withholding Treatment

2011

Trials

1 trial(s) available for vancomycin and Bowel Diseases, Inflammatory

ArticleYear
Risk factors and outcome of PCR-detected Clostridium difficile infection in ileal pouch patients.
    Inflammatory bowel diseases, 2013, Volume: 19, Issue:2

    Topics: Adult; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; Feces; Female; Follow-Up Studies; Humans; Inflammatory Bowel Diseases; Logistic Models; Male; Middle Aged; Multivariate Analysis; Polymerase Chain Reaction; Postoperative Complications; Pouchitis; Proctocolectomy, Restorative; Prospective Studies; Recurrence; Risk Factors; Treatment Outcome; Vancomycin

2013

Other Studies

24 other study(ies) available for vancomycin and Bowel Diseases, Inflammatory

ArticleYear
vanD and vanG-like gene clusters in a Ruminococcus species isolated from human bowel flora.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:11

    Topics: Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Feces; Gene Order; Genes, Bacterial; Humans; Inflammatory Bowel Diseases; Molecular Sequence Data; Multigene Family; Phylogeny; Ruminococcus; Sequence Analysis, DNA; Teicoplanin; Vancomycin

2007
Charge-reversible and biodegradable chitosan-based microgels for lysozyme-triggered release of vancomycin.
    Journal of advanced research, 2023, Volume: 43

    Topics: Chitosan; Drug Delivery Systems; Inflammatory Bowel Diseases; Microgels; Muramidase; Vancomycin

2023
Fidaxomicin treatment for Clostridioides difficile infection in patients with inflammatory bowel disease.
    Journal of gastroenterology and hepatology, 2023, Volume: 38, Issue:11

    Topics: Adult; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Female; Fidaxomicin; Humans; Inflammatory Bowel Diseases; Male; Recurrence; Retrospective Studies; Treatment Outcome; Vancomycin

2023
Isolation, identification, and significance of salivary
    Frontiers in cellular and infection microbiology, 2023, Volume: 13

    Topics: Agar; Bacteria; Humans; Inflammatory Bowel Diseases; Prevotella; RNA, Ribosomal, 16S; Vancomycin; Veillonella

2023
Long-Duration Oral Vancomycin to Treat Clostridioides difficile in Patients With Inflammatory Bowel Disease Is Associated With a Low Rate of Recurrence.
    The American journal of gastroenterology, 2019, Volume: 114, Issue:12

    Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Colitis; Duration of Therapy; Female; Humans; Inflammatory Bowel Diseases; Male; Middle Aged; Recurrence; Vancomycin; Young Adult

2019
Cost-effectiveness analysis of fecal microbiota transplantation for recurrent Clostridium difficile infection in patients with inflammatory bowel disease.
    Journal of gastroenterology and hepatology, 2020, Volume: 35, Issue:9

    Topics: Antibodies, Monoclonal; Broadly Neutralizing Antibodies; Clostridium Infections; Cost-Benefit Analysis; Costs and Cost Analysis; Fecal Microbiota Transplantation; Fidaxomicin; Health Personnel; Hong Kong; Humans; Inflammatory Bowel Diseases; Public Health; Quality-Adjusted Life Years; Recurrence; Treatment Outcome; Vancomycin

2020
Long-term oral vancomycin for refractory inflammatory bowel diseases without Clostridium difficile infection: Lessons from primary sclerosing cholangitis.
    Medical hypotheses, 2020, Volume: 144

    Topics: Cholangitis, Sclerosing; Clostridium Infections; Dysbiosis; Humans; Inflammatory Bowel Diseases; Vancomycin

2020
Gut microbiota-derived short-chain fatty acids regulate IL-17 production by mouse and human intestinal γδ T cells.
    Cell reports, 2021, 07-06, Volume: 36, Issue:1

    Topics: Adult; Animals; Cecum; Fatty Acids, Volatile; Female; Gastrointestinal Microbiome; Gastrointestinal Tract; Histone Deacetylase Inhibitors; Humans; Inflammatory Bowel Diseases; Interleukin-17; Interleukin-22; Interleukins; Intestines; Male; Mice; Mice, Inbred C57BL; Middle Aged; Receptors, Antigen, T-Cell, gamma-delta; Vancomycin

2021
Enteric Infection in Relapse of Inflammatory Bowel Disease: The Utility of Stool Microbial PCR Testing.
    Inflammatory bowel diseases, 2017, Volume: 23, Issue:6

    Topics: Adolescent; Adult; Clostridium Infections; Colectomy; Cross-Sectional Studies; Escherichia coli; Feces; Female; Humans; Incidence; Inflammatory Bowel Diseases; Length of Stay; Logistic Models; Male; Middle Aged; New York City; Polymerase Chain Reaction; Recurrence; Vancomycin; Young Adult

2017
Selective Induction of Homeostatic Th17 Cells in the Murine Intestine by Cholera Toxin Interacting with the Microbiota.
    Journal of immunology (Baltimore, Md. : 1950), 2017, 07-01, Volume: 199, Issue:1

    Topics: Animals; Cholera Toxin; Gastrointestinal Microbiome; Gene Expression Profiling; Germ-Free Life; Homeostasis; IgA Deficiency; Immunoglobulin A; Inflammatory Bowel Diseases; Intestinal Mucosa; Intestine, Small; Mice; Mice, Inbred C57BL; Th17 Cells; Vancomycin

2017
Oral Vancomycin and Gentamicin for Treatment of Very Early Onset Inflammatory Bowel Disease.
    Digestion, 2017, Volume: 95, Issue:4

    Topics: Administration, Oral; Age of Onset; Anti-Bacterial Agents; Child, Preschool; Drug Therapy, Combination; Female; Gentamicins; Humans; Infant; Inflammatory Bowel Diseases; Male; Vancomycin

2017
Vancomycin in Very-Early Onset Inflammatory Bowel Disease-Dysbiosis: Fight Fire with Fire?
    Digestion, 2017, Volume: 95, Issue:4

    Topics: Age Factors; Anti-Bacterial Agents; Dysbiosis; Fecal Microbiota Transplantation; Gastrointestinal Microbiome; Humans; Inflammatory Bowel Diseases; Treatment Outcome; Vancomycin

2017
NLRP1 restricts butyrate producing commensals to exacerbate inflammatory bowel disease.
    Nature communications, 2018, 09-13, Volume: 9, Issue:1

    Topics: Adaptor Proteins, Signal Transducing; Animals; Apoptosis Regulatory Proteins; Butyrates; Clostridiales; Colitis; Colon; Female; Gastrointestinal Microbiome; Gene Deletion; Humans; Inflammasomes; Inflammatory Bowel Diseases; Interferon-gamma; Interleukin-18; Intestinal Mucosa; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; NLR Proteins; Rectum; Signal Transduction; T-Lymphocytes; Vancomycin

2018
Fecal Microbiota Transplant for Recurrent Clostridium difficile Infection in Pediatric Inflammatory Bowel Disease.
    Journal of pediatric gastroenterology and nutrition, 2019, Volume: 68, Issue:3

    Topics: Adolescent; Anti-Bacterial Agents; Child; Clostridium Infections; Fecal Microbiota Transplantation; Female; Humans; Inflammatory Bowel Diseases; Longitudinal Studies; Male; Recurrence; Retrospective Studies; Severity of Illness Index; Vancomycin

2019
Antibiotics for Treatment of Clostridium difficile Infection in Hospitalized Patients with Inflammatory Bowel Disease.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:9

    Topics: Adult; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Female; Hospitalization; Humans; Inflammatory Bowel Diseases; Male; Metronidazole; Retrospective Studies; Treatment Outcome; Vancomycin

2014
Commensal Gram-positive bacteria initiates colitis by inducing monocyte/macrophage mobilization.
    Mucosal immunology, 2015, Volume: 8, Issue:1

    Topics: Animals; Cell Movement; Cells, Cultured; Colitis; Colon; Dextran Sulfate; Disease Models, Animal; Down-Regulation; Epithelial Cells; Gram-Positive Bacteria; Humans; Inflammatory Bowel Diseases; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Monocytes; Receptors, CCR2; Tumor Necrosis Factor-alpha; Vancomycin

2015
Clostridium difficile Ileitis in Pediatric Inflammatory Bowel Disease.
    Journal of pediatric gastroenterology and nutrition, 2017, Volume: 64, Issue:6

    Topics: Adolescent; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Female; Humans; Ileitis; Inflammatory Bowel Diseases; Tomography, X-Ray Computed; Vancomycin

2017
Clostridium difficile infections: emerging epidemiology and new treatments.
    Journal of pediatric gastroenterology and nutrition, 2009, Volume: 48 Suppl 2

    Topics: Anti-Bacterial Agents; Child; Clostridioides difficile; Clostridium Infections; Humans; Immunotherapy; Inflammatory Bowel Diseases; Probiotics; Risk Factors; Vancomycin; Virulence Factors

2009
Clostridium difficile infection in Polish pediatric outpatients with inflammatory bowel disease.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2010, Volume: 29, Issue:10

    Topics: Adolescent; Ambulatory Care; Anti-Bacterial Agents; Child; Child, Preschool; Clostridioides difficile; Clostridium Infections; DNA, Bacterial; Feces; Female; Humans; Inflammatory Bowel Diseases; Male; Metronidazole; Microbial Sensitivity Tests; Prevalence; Recurrence; Ribotyping; Rifampin; Severity of Illness Index; Vancomycin

2010
Clostridium difficile infection and treatment in the pediatric inflammatory bowel disease population.
    Journal of pediatric gastroenterology and nutrition, 2011, Volume: 52, Issue:4

    Topics: Adolescent; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Child; Clostridioides difficile; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Enterotoxins; Feces; Female; Hospitals, Pediatric; Humans; Incidence; Inflammatory Bowel Diseases; Male; Metronidazole; Ohio; Retrospective Studies; Secondary Prevention; Vancomycin

2011
Increased risk of vancomycin-resistant enterococcus (VRE) infection among patients hospitalized for inflammatory bowel disease in the United States.
    Inflammatory bowel diseases, 2011, Volume: 17, Issue:6

    Topics: Adult; Case-Control Studies; Chi-Square Distribution; Confidence Intervals; Cross Infection; Drug Resistance, Bacterial; Enterococcus; Female; Gram-Positive Bacterial Infections; Hospital Costs; Hospitalization; Humans; Inflammatory Bowel Diseases; Length of Stay; Logistic Models; Male; Middle Aged; Odds Ratio; Prevalence; Risk Factors; United States; Vancomycin

2011
Prevalence and predictors of MRSA, ESBL, and VRE colonization in the ambulatory IBD population.
    Journal of Crohn's & colitis, 2012, Volume: 6, Issue:7

    Topics: Adult; Aged; Ambulatory Care; Anti-Bacterial Agents; beta-Lactamases; Carrier State; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Enterococcus; Female; Histamine H2 Antagonists; Hospitalization; Humans; Inflammatory Bowel Diseases; Logistic Models; Male; Methicillin-Resistant Staphylococcus aureus; Metronidazole; Middle Aged; Nose; Prevalence; Proton Pump Inhibitors; Rectum; Risk Factors; Staphylococcal Infections; Vancomycin; Vancomycin Resistance; Young Adult

2012
Antibiotic exposure and IBD development among children: a population-based cohort study.
    Pediatrics, 2012, Volume: 130, Issue:4

    Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Carbapenems; Cefoxitin; Child; Child, Preschool; Clindamycin; Cohort Studies; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Incidence; Inflammatory Bowel Diseases; Logistic Models; Male; Metronidazole; Penicillins; Proportional Hazards Models; Retrospective Studies; Risk; Tetracycline; United Kingdom; Vancomycin

2012
Immunomodulatory effect of vancomycin on Treg in pediatric inflammatory bowel disease and primary sclerosing cholangitis.
    Journal of clinical immunology, 2013, Volume: 33, Issue:2

    Topics: Adolescent; Alanine Transaminase; Blood Cell Count; Child; Child, Preschool; Cholangitis, Sclerosing; Cytokines; Female; gamma-Glutamyltransferase; Humans; Immunologic Factors; Inflammatory Bowel Diseases; Liver Function Tests; Longitudinal Studies; Male; T-Lymphocytes, Regulatory; Treatment Outcome; Vancomycin

2013